Loading...
Sartorius AG
SOAGY•PNK
Healthcare
Medical - Instruments & Supplies
$45.69
$-1.34(-2.85%)
Sartorius AG (SOAGY) Financial Performance & Statements
Review Sartorius AG’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-0.44%
↓ 0.44%
Operating Income Growth
-19.51%
↓ 19.51%
Net Income Growth
-59.06%
↓ 59.06%
Operating Cash Flow Growth
14.36%
↑ 14.36%
Operating Margin
13.12%
↑ 13.12%
Gross Margin
45.27%
↑ 45.27%
Net Profit Margin
3.63%
↑ 3.63%
ROE
4.61%
↑ 4.61%
ROIC
5.24%
↑ 5.24%
Sartorius AG (SOAGY) Financial Statements
Explore quarterly and annual reports for Sartorius AG stock.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $883.00M | $906.80M | $793.60M | $860.70M |
Cost of Revenue | $452.00M | $512.20M | $448.50M | $472.40M |
Gross Profit | $431.00M | $394.60M | $345.10M | $388.30M |
Gross Profit Ratio | $0.49 | $0.44 | $0.43 | $0.45 |
R&D Expenses | $49.70M | $59.40M | $46.80M | $45.70M |
SG&A Expenses | $231.90M | $218.30M | $216.70M | $225.20M |
Operating Expenses | $293.50M | $394.60M | $276.90M | $240.30M |
Total Costs & Expenses | $745.50M | $906.80M | $725.40M | $712.70M |
Interest Income | $54.90M | $0.00 | $11.60M | $17.60M |
Interest Expense | $92.80M | $0.00 | $48.90M | $71.40M |
Depreciation & Amortization | $103.50M | $119.00M | $101.40M | $99.80M |
EBITDA | $295.80M | $148.50M | $181.20M | $206.10M |
EBITDA Ratio | $0.33 | $0.16 | $0.23 | $0.24 |
Operating Income | $137.50M | $0.00 | $68.20M | $148.00M |
Operating Income Ratio | $0.16 | $0.00 | $0.09 | $0.17 |
Other Income/Expenses (Net) | -$38.00M | $30.00M | -$37.30M | -$95.60M |
Income Before Tax | $99.50M | $30.00M | $30.90M | $52.40M |
Income Before Tax Ratio | $0.11 | $0.03 | $0.04 | $0.06 |
Income Tax Expense | $26.90M | $7.30M | $8.40M | $13.90M |
Net Income | $48.50M | $44.40M | $8.30M | $23.90M |
Net Income Ratio | $0.05 | $0.05 | $0.01 | $0.03 |
EPS | $0.70 | $0.13 | $0.12 | $0.35 |
Diluted EPS | $0.70 | $0.13 | $0.12 | $0.35 |
Weighted Avg Shares Outstanding | $69.29M | $69.04M | $69.04M | $69.04M |
Weighted Avg Shares Outstanding (Diluted) | $69.29M | $69.04M | $69.04M | $69.04M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan